Autopsy report · NCT04968860

Oral Health Condition and Quality of Life in Children With Leukemia

“Low casuistry that did not allow the study to continue”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months after it had already started.
• Ran for about 3 years 4 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Paulo Sergio da Silva Santos

Sponsor type

University, hospital or other

Conditions

Leukemia, Lymphoblastic; Leukemia, Myeloid, Acute

Interventions

This study is observational

Participants

9

Sites

1

Countries

Brazil

Trials that died the same way

• Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
  “Study discontinued due to low accrual.” (69% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (68% match in meaning)
• Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
  “The study was terminated due to low accrual.” (67% match in meaning)
• Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
  “the study had a low accrual rate” (67% match in meaning)
• Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
  “Study was closed to low accrual.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.